NASDAQ · BIOS
BioPlus Acquisition Corp.
$10.80-$0.01 (-0.05%)
BioPlus Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 7.58% below the high.
Loading market information…
NASDAQ · USCT · USD
Stock price, earnings
Quote as of Jun 17, 2025, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
TKB Critical Technologies 1’s quoted price sits in the lower half of its reported 52-week range, 11.73% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow TKB Critical Technologies 1’s reporting calendar.
THE COMPANY BEHIND THE TICKER
TKB Critical Technologies 1 is presently without any significant active business operations. Its primary objective is to execute a strategic amalgamation or partnership with one or more enterprises, which might take the form of a merger, a capital stock exchange, an asset acquisition, an equity purchase, a corporate restructuring, or another comparable business consolidation. The company is specifically targeting ventures engaged in a broad spectrum of cutting-edge technological sectors, including advanced manufacturing, artificial intelligence (AI), automation, cybersecurity, energy storage and power management solutions, financial technology (FinTech), industrial software, the Internet of Things (IoT), microelectronics, robotics, and wireless communication hardware. This entity was established in 2021 and is based in El Segundo, California.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:53 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$10.80-$0.01 (-0.05%)
BioPlus Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 7.58% below the high.
$10.74-$0.03 (-0.28%)
Compass Digital Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 14.08% below the high.
$0.00-$0.01 (-98.0%)
Altimar Acquisition Corp. III: Financial Services · Shell Companies.
$3.55$0.00 (0.0%)
Alpha One Inc.’s quoted price sits in the lower half of its reported 52-week range, 19.68% below the high.
$10.30+$2.46 (+31.3%)
AlphaVest Acquisition Corp’s quoted price sits in the lower half of its reported 52-week range, 75.48% below the high.
$11.20+$0.09 (+0.81%)
Achari Ventures Holdings Corp. I’s quoted price sits in the upper half of its reported 52-week range, 10.04% below the high.
$12.75$0.00 (0.0%)
ClimateRock’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$7.35+$0.89 (+13.78%)
American Acquisition Opportunity Inc.’s quoted price sits in the lower half of its reported 52-week range, 52.58% below the high.
